Clinical Report: Reintroduction of Winged Infusion Sets in NSPs
Overview
The reintroduction of winged infusion sets and larger-volume syringes in New South Wales' Needle and Syringe Program has led to a significant increase in methadone-related service utilization. Clients reported improved health and safety outcomes following access to these resources.
Background
The reintroduction of winged infusion sets in NSPs addresses a critical gap in harm reduction for individuals who inject methadone. Historically, the prohibition of such equipment created barriers to safe injection practices, impacting health equity. Recent policy changes reflect a shift towards more inclusive harm reduction strategies.
Data Highlights
Metric
Before Introduction
After Introduction
Monthly Methadone-related Attendances
2.2
4.0
Client Reports of Improved Health/Safety
N/A
89%
Key Findings
The NSW NSP Guidelines allowed the distribution of winged infusion sets and larger syringes in January 2023.
Kirketon Road Centre began distributing 'butterfly packs' in April 2023.
There was a significant increase in NSP visits by clients reporting methadone as the last drug injected.
89% of survey respondents reported improved health or safety after accessing butterfly packs.
The policy change aims to enhance equity in harm reduction for people who inject methadone.
Clinical Implications
The availability of winged infusion sets and larger syringes can facilitate safer injection practices among individuals using methadone. Tailoring harm reduction services to meet the specific needs of vulnerable populations is essential for improving health outcomes.
Conclusion
The reintroduction of equipment for intravenous methadone administration represents a significant advancement in harm reduction efforts in New South Wales. This initiative underscores the importance of equitable access to health services.
